Dostarlimab or pembrolizumab plus chemotherapy in previously untreated metastatic non-squamous non-small cell lung cancer: the randomized PERLA phase II trial

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

Extent: 1 Online-Ressource.

Language: Englisch

Bibliographic citation: Dostarlimab or pembrolizumab plus chemotherapy in previously untreated metastatic non-squamous non-small cell lung cancer: the randomized PERLA phase II trial ; volume:14 ; number:1 ; day:11 ; month:11 ; year:2023 ; pages:1-12 ; date:12.2023
Nature Communications ; 14, Heft 1 (11.11.2023), 1-12, 12.2023

Creator: Lim, Sun Min
Peters, Solange
Ortega Granados, Ana Laura
Pinto, Gustavo dix Junqueira
Fuentes, Christian Sebastián
Lo Russo, Giuseppe
Schenker, Michael
Ahn, Jin Seok
Reck, Martin
Szijgyarto, Zsolt
Huseinovic, Neda
Zografos, Eleftherios
Buss, Elena
Stjepanovic, Neda
O’Donnell, Sean
Marinis, Filippo de

Contributor: SpringerLink (Online service)

DOI: 10.1038/s41467-023-42900-4

URN: urn:nbn:de:101:1-2024013013010840357060

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 15.08.2025, 7:33 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Lim, Sun Min
Peters, Solange
Ortega Granados, Ana Laura
Pinto, Gustavo dix Junqueira
Fuentes, Christian Sebastián
Lo Russo, Giuseppe
Schenker, Michael
Ahn, Jin Seok
Reck, Martin
Szijgyarto, Zsolt
Huseinovic, Neda
Zografos, Eleftherios
Buss, Elena
Stjepanovic, Neda
O’Donnell, Sean
Marinis, Filippo de
SpringerLink (Online service)

Other Objects (12)

Pembrolizumab-Induced Adrenal Insufficiency in Patients with Untreated Advanced Non-Small Cell Lung Cancer: A Case Series

KEYNOTE-434 part B: A phase 1 study evaluating the combination of epacadostat, pembrolizumab, and chemotherapy in Japanese patients with previously untreated advanced non–small-cell lung cancer

Intraoperative radiation therapy (IORT) for previously untreated malignant gliomas

Osimertinib: A Review in Previously Untreated, EGFR Mutation-Positive, Advanced NSCLC

Role of inflammation in previously untreated macular edema with branch retinal vein occlusion

Correction to: Osimertinib: A Review in Previously Untreated, EGFR Mutation-Positive, Advanced NSCLC

Pembrolizumab with or without enzalutamide in selected populations of men with previously untreated metastatic castration-resistant prostate cancer harbouring programmed cell death ligand-1 staining: a retrospective study

Pneumonitis associated with pembrolizumab plus chemotherapy for non-squamous non-small cell lung cancer

Clinical outcomes of previously untreated patients with unresectable intrahepatic cholangiocarcinoma following proton beam therapy

P1.14 PWV Improvement in Previously Untreated Mild Hypertensive Patients After 1 Year of Monotherapy

Expectations and perception of cancer treatment goals in previously untreated patients. The EXPECT trial

Cost-effectiveness analysis of ceritinib vs. crizotinib in previously untreated anaplastic lymphoma kinase (ALK)-positive non-small cell lung cancer (NSCLC) in Hong Kong

Pembrolizumab-Induced Adrenal Insufficiency in Patients with Untreated Advanced Non-Small Cell Lung Cancer: A Case Series

KEYNOTE-434 part B: A phase 1 study evaluating the combination of epacadostat, pembrolizumab, and chemotherapy in Japanese patients with previously untreated advanced non–small-cell lung cancer

Intraoperative radiation therapy (IORT) for previously untreated malignant gliomas

Osimertinib: A Review in Previously Untreated, EGFR Mutation-Positive, Advanced NSCLC

Role of inflammation in previously untreated macular edema with branch retinal vein occlusion

Correction to: Osimertinib: A Review in Previously Untreated, EGFR Mutation-Positive, Advanced NSCLC

Pembrolizumab with or without enzalutamide in selected populations of men with previously untreated metastatic castration-resistant prostate cancer harbouring programmed cell death ligand-1 staining: a retrospective study

Pneumonitis associated with pembrolizumab plus chemotherapy for non-squamous non-small cell lung cancer

Clinical outcomes of previously untreated patients with unresectable intrahepatic cholangiocarcinoma following proton beam therapy

P1.14 PWV Improvement in Previously Untreated Mild Hypertensive Patients After 1 Year of Monotherapy

Expectations and perception of cancer treatment goals in previously untreated patients. The EXPECT trial

Cost-effectiveness analysis of ceritinib vs. crizotinib in previously untreated anaplastic lymphoma kinase (ALK)-positive non-small cell lung cancer (NSCLC) in Hong Kong

Pembrolizumab-Induced Adrenal Insufficiency in Patients with Untreated Advanced Non-Small Cell Lung Cancer: A Case Series

KEYNOTE-434 part B: A phase 1 study evaluating the combination of epacadostat, pembrolizumab, and chemotherapy in Japanese patients with previously untreated advanced non–small-cell lung cancer

Intraoperative radiation therapy (IORT) for previously untreated malignant gliomas

Osimertinib: A Review in Previously Untreated, EGFR Mutation-Positive, Advanced NSCLC

Role of inflammation in previously untreated macular edema with branch retinal vein occlusion

Correction to: Osimertinib: A Review in Previously Untreated, EGFR Mutation-Positive, Advanced NSCLC

Pembrolizumab with or without enzalutamide in selected populations of men with previously untreated metastatic castration-resistant prostate cancer harbouring programmed cell death ligand-1 staining: a retrospective study

Pneumonitis associated with pembrolizumab plus chemotherapy for non-squamous non-small cell lung cancer

Clinical outcomes of previously untreated patients with unresectable intrahepatic cholangiocarcinoma following proton beam therapy

P1.14 PWV Improvement in Previously Untreated Mild Hypertensive Patients After 1 Year of Monotherapy

Expectations and perception of cancer treatment goals in previously untreated patients. The EXPECT trial

Cost-effectiveness analysis of ceritinib vs. crizotinib in previously untreated anaplastic lymphoma kinase (ALK)-positive non-small cell lung cancer (NSCLC) in Hong Kong

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Dostarlimab or pembrolizumab plus chemotherapy in previously untreated metastatic non-squamous non-small cell lung cancer: the randomized PERLA phase II trial

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Pembrolizumab-Induced Adrenal Insufficiency in Patients with Untreated Advanced Non-Small Cell Lung Cancer: A Case Series

KEYNOTE-434 part B: A phase 1 study evaluating the combination of epacadostat, pembrolizumab, and chemotherapy in Japanese patients with previously untreated advanced non–small-cell lung cancer

Intraoperative radiation therapy (IORT) for previously untreated malignant gliomas

Osimertinib: A Review in Previously Untreated, EGFR Mutation-Positive, Advanced NSCLC

Role of inflammation in previously untreated macular edema with branch retinal vein occlusion

Correction to: Osimertinib: A Review in Previously Untreated, EGFR Mutation-Positive, Advanced NSCLC

Pembrolizumab with or without enzalutamide in selected populations of men with previously untreated metastatic castration-resistant prostate cancer harbouring programmed cell death ligand-1 staining: a retrospective study

Pneumonitis associated with pembrolizumab plus chemotherapy for non-squamous non-small cell lung cancer

Clinical outcomes of previously untreated patients with unresectable intrahepatic cholangiocarcinoma following proton beam therapy

P1.14 PWV Improvement in Previously Untreated Mild Hypertensive Patients After 1 Year of Monotherapy

Expectations and perception of cancer treatment goals in previously untreated patients. The EXPECT trial

Cost-effectiveness analysis of ceritinib vs. crizotinib in previously untreated anaplastic lymphoma kinase (ALK)-positive non-small cell lung cancer (NSCLC) in Hong Kong

Pembrolizumab-Induced Adrenal Insufficiency in Patients with Untreated Advanced Non-Small Cell Lung Cancer: A Case Series

KEYNOTE-434 part B: A phase 1 study evaluating the combination of epacadostat, pembrolizumab, and chemotherapy in Japanese patients with previously untreated advanced non–small-cell lung cancer

Intraoperative radiation therapy (IORT) for previously untreated malignant gliomas

Osimertinib: A Review in Previously Untreated, EGFR Mutation-Positive, Advanced NSCLC

Role of inflammation in previously untreated macular edema with branch retinal vein occlusion

Correction to: Osimertinib: A Review in Previously Untreated, EGFR Mutation-Positive, Advanced NSCLC

Pembrolizumab with or without enzalutamide in selected populations of men with previously untreated metastatic castration-resistant prostate cancer harbouring programmed cell death ligand-1 staining: a retrospective study

Pneumonitis associated with pembrolizumab plus chemotherapy for non-squamous non-small cell lung cancer

Clinical outcomes of previously untreated patients with unresectable intrahepatic cholangiocarcinoma following proton beam therapy

P1.14 PWV Improvement in Previously Untreated Mild Hypertensive Patients After 1 Year of Monotherapy

Expectations and perception of cancer treatment goals in previously untreated patients. The EXPECT trial

Cost-effectiveness analysis of ceritinib vs. crizotinib in previously untreated anaplastic lymphoma kinase (ALK)-positive non-small cell lung cancer (NSCLC) in Hong Kong

Pembrolizumab-Induced Adrenal Insufficiency in Patients with Untreated Advanced Non-Small Cell Lung Cancer: A Case Series

KEYNOTE-434 part B: A phase 1 study evaluating the combination of epacadostat, pembrolizumab, and chemotherapy in Japanese patients with previously untreated advanced non–small-cell lung cancer

Intraoperative radiation therapy (IORT) for previously untreated malignant gliomas

Osimertinib: A Review in Previously Untreated, EGFR Mutation-Positive, Advanced NSCLC

Role of inflammation in previously untreated macular edema with branch retinal vein occlusion

Correction to: Osimertinib: A Review in Previously Untreated, EGFR Mutation-Positive, Advanced NSCLC

Pembrolizumab with or without enzalutamide in selected populations of men with previously untreated metastatic castration-resistant prostate cancer harbouring programmed cell death ligand-1 staining: a retrospective study

Pneumonitis associated with pembrolizumab plus chemotherapy for non-squamous non-small cell lung cancer

Clinical outcomes of previously untreated patients with unresectable intrahepatic cholangiocarcinoma following proton beam therapy

P1.14 PWV Improvement in Previously Untreated Mild Hypertensive Patients After 1 Year of Monotherapy

Expectations and perception of cancer treatment goals in previously untreated patients. The EXPECT trial

Cost-effectiveness analysis of ceritinib vs. crizotinib in previously untreated anaplastic lymphoma kinase (ALK)-positive non-small cell lung cancer (NSCLC) in Hong Kong

Related objects

Reset password